EUVIMEDEUVIMED entdecken
Crossref

Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study

Min Rui, Lei Jiang, Jia-Jun Pan, Xue-Ting Huang, Jia-Fang Cui, Shi-Jia Zhang, Su-Mei He, Huan-Huan Han, Xiao Chen, Dong-Dong Wang

International Urology and Nephrology · 2024

DOI: 10.1007/s11255-024-04056-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Urology and Nephrology, 2024. Verfasst von Min Rui und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The Affiliated Jiangyin Clinical College of Xuzhou Medical University, Jiangyin, 214400, Jiangsu, China. Hauptthemen laut MEDLINE: Glomerulonephritis, Membranous, Immunosuppressive Agents, Machine Learning, Proteinuria. Die Arbeit nennt 36 Literaturangaben. Gefördert von: The Xuzhou Special fund for promoting scientific and technological innovation, The Initializing Fund of Xuzhou Medical University, Innovation Program in Military Medicine of Chinese People's Liberation Army.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The present study aims to explore the effects of tacrolimus on proteinuria in patients with idiopathic membranous nephropathy (IMN) and recommend an appropriate dosage schedule via machine learning method. METHODS: The Emax model was constructed to analyze the effects of tacrolimus on proteinuria in patients with IMN. Data were mined from published literature and machine learning was built up with Emax model, among which the efficacy indicator was proteinuria change rates from baseline. 463 IMN patients were included for modeling, and tacrolimus therapeutic window concentrations were 4-10 ng/ml. RESULTS: In machine learning model, the Emax from tacrolimus effecting proteinuria in IMN patients was -72.7%, the ET50 was 0.43 months, and the time to achieving 25% Emax, 50% Emax, 75% Emax, and 80% (plateau) Emax of tacrolimus on proteinuria in patients with IMN were 0.15, 0.43, 1.29, and 1.72 months, respectively. CONCLUSION: For achieving better therapeutic effects from tacrolimus on proteinuria in patients with IMN, tacrolimus concentration range need to be maintained at 4-10 ng/ml for at least 1.72 months.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, MembranousImmunosuppressive AgentsMachine LearningProteinuriaTacrolimusAdultFemaleHumansMaleMiddle AgedChinaEast Asian PeopleIndiaSouth Asian People

Stichwörter der Autor:innen

Idiopathic membranous nephropathyMachine learningPredictionProteinuriaTacrolimus

Substanzen

Immunosuppressive AgentsTacrolimus

Autor:innen und Institutionen

  • Department of Orthopaedics, The Affiliated Jiangyin Clinical College of Xuzhou Medical University, Jiangyin, 214400, Jiangsu, China.
  • Department of Pharmacy, Taixing People's Hospital, Taixing, 225400, Jiangsu, China.
  • Department of Thoracic Cardiovascular Surgery, The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou, 221100, Jiangsu, China.
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy and School of Pharmacy, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.
  • Department of Pharmacy, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, 215153, Jiangsu, China. hehe8204@163.com.
  • Department of Pharmacy, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, 222000, Jiangsu, China. 18961321750@163.com.

Förderung

  • The Xuzhou Special fund for promoting scientific and technological innovation
  • The Initializing Fund of Xuzhou Medical University
  • Innovation Program in Military Medicine of Chinese People's Liberation Army
  • The Fusion Innovation Project of Xuzhou Medical University
  • The Medical Research Project of Jiangsu Provincial Health Commission
  • Innovation Program in Military Medicine of Chinese People’s Liberation Army

Zitieren

APA

Rui, M., Jiang, L., Pan, J. J., Huang, X. T., Cui, J. F., Zhang, S. J., He, S. M., Han, H. H., Chen, X., & Wang, D. D. (2024). Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study. International Urology and Nephrology. https://doi.org/10.1007/s11255-024-04056-y

Vancouver

Rui M, Jiang L, Pan JJ, Huang XT, Cui JF, Zhang SJ, et al. Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study. International Urology and Nephrology. 2024. doi:10.1007/s11255-024-04056-y

BibTeX
@article{Rui2024,
  author = {Rui, Min and Jiang, Lei and Pan, Jia-Jun and Huang, Xue-Ting and Cui, Jia-Fang and Zhang, Shi-Jia and He, Su-Mei and Han, Huan-Huan and Chen, Xiao and Wang, Dong-Dong},
  title = {Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study},
  journal = {International Urology and Nephrology},
  year = {2024},
  doi = {10.1007/s11255-024-04056-y}
}
Kostenlos starten →